CTNM compared with CAPR: revenue, margins and what each company keeps, and the suppliers and customers both name

CTNMContineum Therapeutics, Inc.

Mkt capRevenueRevenue

CAPRCapricor Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CTNMContineum Therapeutics, Inc.

CAPRCapricor Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CTNM2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±35.1%▲+1.03%×0.03

Q2 FY26—▼−1.65%—

CAPR

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±35.1%▲+57.96%×1.65

May 13 '26±9.0%▼−3.78%×0.42

= impliedCTNM realized, solidCAPR realized, hatchedOne scale, both sides: full bar = 58%× = |realized| ÷ impliedspan: CTNM 96d · CAPR 276dSource: market data

Q1 FY26

±10.0%

▼−8.74%

×0.87

Q3 FY25±50.7%▲+11.51%×0.23

CTNMContineum Therapeutics, Inc.

9.62▲+9.19%· post 9.62

Mkt cap$373.8MRevenue—Revenue—

CAPRCapricor Therapeutics, Inc.

9.01▲+4.78%· post 8.98

ClosedNov 6 '26

Mkt cap$523.3MRevenue$11MQ4 FY24Revenue$22MFY24

Compare

ClosedNov 6 '26

CTNMContineum Therapeutics, Inc.

CAPRCapricor Therapeutics, Inc.

9.62▲+9.19%post 9.62

Price

9.01▲+4.78%post 8.98

$373.8M

Mkt cap

$523.3M

—

Revenue

$11MQ4 FY24

—

Revenue

$22MFY24

CTNM9.62▲+9.19%vsCAPR9.01▲+4.78%ClosedNov 6 '26